TOLERO PHARMACEUTICALS
Tolero Pharmaceuticals is a biopharmaceutical company that discovers and develops novel therapeutics to treat and cure cancer and other life-threatening diseases in the United States. Its products include TP-0413 that targets a signaling pathway complicated in the regulation of serum iron levels for individuals suffering from chronic inflammatory diseases, such as cancer and rheumatoid arthritis; TP-0829, which targets a vital component of the B-cell receptor signaling pathway for the treatment ... of B-cell lymphomas, B-cell leukemia, and multiple myeloma; and TP-0903, a dual-targeted agent that inhibits two signaling pathways for pancreatic cancer cell growth and survival, and for the maintenance of the tumor stromal cells. The company’s products also comprise TP-0227 that targets a signaling pathway deregulated in cancer cells particularly in endometrial carcinomas; and TP-1149 which targets a cellular mechanism to render myeloma cells resistant to current therapeutic approaches. Tolero Pharmaceuticals, Inc. has a strategic partnership with MannKind Corporation. The company was founded in 2011 and is based in Salt Lake City, Utah.
TOLERO PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2011-01-01
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.toleropharmaceuticals.com
Total Employee:
11+
Status:
Active
Contact:
801-285-6003
Total Funding:
25.93 M USD
Technology used in webpage:
SPF Amazon AJAX Libraries API GoDaddy DNS AWS Global Accelerator
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Nanomed Pharameceuticals
NanoMed Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutic products to treat cancer and other diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.toleropharmaceuticals.com
- Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
- IP address: 15.197.142.173
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Tolero Pharmaceuticals"
Tolero Pharmaceuticals - Crunchbase Company Profile & Funding
Tolero Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics to treat cancer and other life-threatening diseases. Search Crunchbase. Start Free Trial . Chrome …See details»
Tolero Pharmaceuticals, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Tolero Pharmaceuticals, Inc. of Lehi, UT. Get the latest business insights from Dun & Bradstreet.See details»
Tolero Pharmaceuticals, Inc. Overview - SignalHire
Tolero Pharmaceuticals, Inc. is a private company that has been in the industry for 13 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals, Biotechnology areas. …See details»
Tolero Pharmaceuticals, Inc. | LinkedIn
Tolero Pharmaceuticals is a clinical stage biopharmaceutical company developing treatments to improve and extend the lives of patients with serious oncological and hematological diseases.See details»
Tolero Pharmaceuticals - PitchBook
Tolero Pharmaceuticals was acquired on 31-Mar-2017. Who acquired Tolero Pharmaceuticals? Tolero Pharmaceuticals was acquired by Sumitomo Pharma. Data Transparency. Meet our data hygiene team. Discover how our experts …See details»
Tolero Pharmaceuticals - Contacts, Employees, Board Members, …
Tolero Pharmaceuticals has 2 current employee profiles, including Founder and Chief Executive Officer David J. Bearss. David J. Bearss Founder and Chief Executive Officer Daniel Hoff …See details»
Tolero Pharmaceuticals, Inc.’s Competitors, Revenue, Number of ...
Tolero Pharmaceuticals, Inc.’s Profile, Revenue and Employees. Tolero Pharmaceuticals discovers and develops novel therapeutics for the treatment of oncology and hematologic …See details»
Tolero Pharmaceuticals - Funding, Financials, Valuation & Investors
Tolero Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics to treat cancer and other life-threatening diseases. Search Crunchbase. Start Free Trial . Chrome …See details»
Sumitomo Dainippon Pharma Completes Acquisition of Tolero ...
Print（PDF/62KB） Jan. 26, 2017 Corporate Sumitomo Dainippon Pharma Completes Acquisition of Tolero Pharmaceuticals, Inc. (US Biotechnology Company) Sumitomo Dainippon Pharma …See details»
Tolero Pharma - Company Profile - Tracxn
Oct 4, 2024 Tolero Pharmaceuticals Presents Findings from First Clinical Studies Evaluating Investigational Agents TP-1287 and TP-3654 in Patients with Advanced Solid Tumors at …See details»
Tolero Pharmaceuticals Inc - Company Profile and News
Tolero Pharmaceuticals Inc., is a biopharmaceutical company. The Company develops novel therapeutics to treat and cure cancer and other life-threatening diseases. ...See details»
Tolero Pharmaceuticals - Crustdata Company Profile, Funding and …
Tolero Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics to treat cancer and other life-threatening diseases. Suggest an Edit. Health Care. Pharmaceutical. …See details»
Tolero Pharmaceuticals, Inc. Management Team | Org Chart
Tolero Pharmaceuticals, Inc. employs 6 employees. The Tolero Pharmaceuticals, Inc. management team includes Mark Wade (Associate Program Director - Biomarker …See details»
Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, …
Dec 21, 2016 Tolero Pharmaceuticals, Inc. (2) Address of Headquarters: 2975 Executive Parkway Suite # 320 Lehi, UT 84043, U.S. (3) Representative: CEO: David J. Bearss (4) …See details»
Tolero Pharmaceuticals - Products, Competitors, Financials, …
Tolero Pharmaceuticals is a biotechnology company specializing in the research and development of therapeutic agents in the areas of oncology and hematological disorders. Tolero possesses …See details»
Tolero Pharmaceuticals company information, funding & investors …
Tolero Pharmaceuticals, a biopharmaceutical company, develops novel therapeutics to treat cancer and other life-threatening diseases. Here you'll find information about their funding, …See details»
Sumitomo Dainippon Pharma Oncology Announces Its Formation …
CAMBRIDGE, Mass., July 1, 2020 /PRNewswire/ -- Sumitomo Dainippon Pharma Oncology, Inc. was formed today through the merger of Tolero Pharmaceuticals, Inc., and Boston Biomedical, …See details»
Acquisition of Tolero Pharmaceuticals, Inc. - Sumitomo Pharma
Acquisition of Tolero Pharmaceuticals, Inc. 1 Acquire attractive compounds with potential to treat hematological disorders Obtain outstanding expertise in drug discovery capabilities for kinase …See details»
Tolero Pharmaceuticals to Be Acquired for Up to $780 Million
December 21, 2016 By Alex Keown, BioSpace.com Breaking News Staff. OSAKA, Japan -- Sumitomo Dainippon Pharma Co. Ltd. is plunking down up to $780 million to acquire Utah …See details»